Weight, metabolism, hormone therapy, and inflammation can all affect health after a breast cancer diagnosis, which is why GLP-1 medications are drawing so much attention
GLP-1 Medication Titration: When to Increase and When to Stay at Your Current Dose Lori Fauquier, APN-C, WHNP Feb 6, 2025 3 min read Updated: Jun 7, 2025 GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have revolutionized medical weight loss, helping individuals control cravings, regulate blood sugar, and achieve sustainable weight loss
2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)
Tirzepatide side effects including muscle pain can occur during the first few months and may relate to rapid body composition changes or electrolyte shifts
Strength training exercises can build and maintain muscle mass, promote overall health and fitness, and even reduce the risk of heart disease
Dual or triple receptor agonists: Some newer compounds target not just GIP & GLP-1 receptors but also GLP-1 + glucagon or even triple agonists